Login
$ELTX
$1.83 +$0.13 (7.65%) Close

Insider Transactions

What Elicio Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 5

Shares traded

3 months 12 months
Acquired 0 144,162
Disposed 0 0
Net activity +0 +144,162

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Haqq Christopher See Remarks Feb 02 Grant / award · A +25,400 — — 57,381
DeMuth Peter Chief Scientific Officer Feb 02 Grant / award · A +20,800 — — 21,543
Connelly Robert CEO, President and Director Feb 02 Grant / award · A +73,600 — — 120,570
Shah Preetam See Remarks Feb 02 Grant / award · A +24,000 — — 24,000
DeMuth Peter Chief Scientific Officer Dec 09 Exercise / conversion · M +362 $4.41 +$1.6K 743
Chudnovsky Yekaterina Director Mar 05 Derivative Conversion · C +3,500,573 $5.81 +$20.3M 5,416,212
DeMuth Peter Chief Scientific Officer Dec 16 Exercise / conversion · M +381 $4.41 +$1.68K 381
Venkatesan Jay Director Nov 26 In/At-money Exercise · X +50,000 $0.01 +$500 179,581
Chudnovsky Yekaterina Director Dec 22 Open-market buy · P +1,213,000 $5.81 +$7.05M 1,915,639
Goldberg Itzhak Director Jul 01 Withheld — tax / exercise cost · F −32,082 $1.12 −$35.9K 1,687,986
Venkatesan Jay See Remarks May 25 Open-market buy · P +11,313 $1.25 +$14.1K 1,891,947
Venkatesan Jay See Remarks May 24 Open-market buy · P +32,200 $1.24 +$39.9K 1,721,457
Nissenson Allen Director May 20 Open-market buy · P +2,037 $1.18 +$2.4K 9,383
Venkatesan Jay See Remarks May 20 Open-market buy · P +50,000 $1.23 +$61.5K 1,689,257
Nissenson Allen Director May 19 Open-market buy · P +7,346 $1.16 +$8.52K 7,346
Venkatesan Jay See Remarks Dec 28 Open-market buy · P +210,337 $2.66 +$560K 1,639,257
Venkatesan Jay See Remarks Dec 27 Open-market buy · P +66,907 $2.55 +$171K 1,428,920
Venkatesan Jay See Remarks Dec 20 Open-market buy · P +3,527 $2.54 +$8.98K 1,362,013
Neylan John F. See Remarks Dec 20 Open-market sale · S −358 $2.62 −$938 35,136
Venkatesan Jay See Remarks Dec 17 Open-market buy · P +13,742 $2.54 +$35K 1,358,486

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support